Clinical Oncology
Volume 22, Issue 10 , Pages 837-843 , December 2010

Validation of Recursive Partitioning Analysis Classification in Patients with Brain Metastases from Non-small Cell Lung Cancer Treated with Short-course Accelerated Radiotherapy

  • J.P. Agarwal

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • Corresponding Author InformationAuthor for correspondence: J.P. Agarwal, Department of Radiation Oncology, Tata Memorial Hospital, Room no. 127, Main Building, Dr Ernest Borges Road, Parel (East), Mumbai 400012, India. Tel: +91-22-24177164; Fax: +91-22-24146937.
    • ,
  • T. Wadasadawala

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • A. Munshi

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • P. Chadda

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • R. Apsani

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • M. Upasani

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • S.G. Laskar

      Affiliations

    • Department of Radiation Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • C.S. Pramesh

      Affiliations

    • Department of Surgical Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • G. Karimundackal

      Affiliations

    • Department of Surgical Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • H. Menon

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • K. Prabhash

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Parel (East), Mumbai, India
    • ,
  • N. Jambhekar

      Affiliations

    • Department of Pathology, Tata Memorial Hospital, Parel (East), Mumbai, India

Received 9 December 2009 ,Revised 10 May 2010 ,Accepted 31 May 2010.

References 

  1. Parkin DM, Bray F, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 2002;2005(55):74–108
  2. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741–744
  3. Mamon HJ, Yeap BY, Jänne PA, et al. High risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005;23:1530–1537
  4. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 2006;3:CD003869
  5. Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJA, Dunst J. Two radiation regimens and prognostic factors for brain metastases in non small cell lung cancer patients. Cancer. 2007;110:1077–1082
  6. Rades D, Bohlen G, Dunst J, et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol. 2008;184:30–35
  7. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol. 2010;34:101–104
  8. Sen S, Ateeq B, Sharma H, et al. Molecular profiling of genes in squamous cell lung carcinoma in Asian Indians. Life Sci. 2008;82:772–779
  9. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001–1006
  10. Bonnette P, Puyo P, Gabriel C, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest. 2001;119:1469–1475
  11. Louie AV, Rodrigues G, Yaremko B, et al. Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer. Clin Lung Cancer. 2009;10:174–179
  12. Videtic GM, Reddy CA, Chao ST, et al. Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis classification. Int J Radiat Oncol Biol Phys. 2009;75:1141–1147
  13. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751
  14. Kepka L, Cieslak E, Bujko K, Fijuth J, Wierzchowski M. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol. 2005;44:389–398
  15. Jacot W, Quantin X, Boher JM, et al. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer. 2001;84:903–909
  16. Robin E, Bitran JD, Golomb HM, et al. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982;49:1916–1919
  17. Novello S, Vavala' T. Lung cancer and women. Future Oncol. 2008;4:705–716
  18. Kim KH, Lee J, Lee JI, et al. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?. Lung Cancer. 2010;68:258–263
  19. Oh Y, Taylor S, Bekele BN, et al. Number of metastatic sites is a strong predictor of survival in patients with non small cell lung cancer with or without brain metastases. Cancer. 2009;115:2930–2938
  20. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet. 2004;363:1665–1672
  21. Zabel A, Milker-Zabel S, Thilmann C, et al. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer. 2002;37:87–94
  22. Flannery TW, Suntharalingam M, Kwok Y, et al. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer. Lung Cancer. 2003;42:327–333
  23. Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. (The IDEAL 1 Trial). [corrected] J Clin Oncol. 2003;21:2237–2246

PII: S0936-6555(10)00194-9

doi: 10.1016/j.clon.2010.05.022

Clinical Oncology
Volume 22, Issue 10 , Pages 837-843 , December 2010

Article Tools

* Image Usage & Resolution